Junshi Biosciences completes registration for A share option grant

Shanghai Junshi Biosciences Co., Ltd. announced the completion of registration for the first grant of A Share Options under its 2025 A Share Option Incentive Scheme. The registration was finalized on November 14, 2025, with 24,700,000 A Share Options registered for 226 participants. This number was adjusted after nine participants waived a total of 450,000 A Share Options. The exercise price for these options is RMB46.67 per A Share, and the A Shares will be newly issued by the company.

The validity period for the scheme will not exceed 48 months, commencing from the grant date of September 29, 2025. Vesting periods for the first grant are set at 12 and 24 months. The total incentive cost, estimated at RMB18,995.25 (0,000), will be amortized across 2025, 2026, and 2027, with RMB3,379.91 (0,000) in 2025, RMB11,508.64 (0,000) in 2026, and RMB4,106.70 (0,000) in 2027.

The 25,515,871 A Shares potentially issuable under the scheme represent approximately 2.49% of the company's total shares in issue as of the adoption date. As of this announcement, 815,871 A Shares remain available for future grants under the scheme mandate limit.